Cargando…
RET-Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity
SIMPLE SUMMARY: Changes in the RET gene (like mutations or fusions) are often found in lung and thyroid cancers but are also found in other cancer types. New drugs called “selective RET inhibitors”, like selpercatinib and pralsetinib, are effective in treating tumors with RET gene changes. These dru...
Autores principales: | Desilets, Antoine, Repetto, Matteo, Yang, Soo-Ryum, Sherman, Eric J., Drilon, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452615/ https://www.ncbi.nlm.nih.gov/pubmed/37627175 http://dx.doi.org/10.3390/cancers15164146 |
Ejemplares similares
-
Targeting RET-rearranged lung cancers with multikinase inhibitors
por: Sabari, Joshua K., et al.
Publicado: (2017) -
Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018) -
Decade in review: a new era for RET-rearranged lung cancers
por: Choudhury, Noura J., et al.
Publicado: (2020) -
RET kinase alterations in targeted cancer therapy
por: Liu, Xuan, et al.
Publicado: (2020) -
Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)